Advocacy

The Rx Drug Price Transparency Act is a step in the right direction towards lowering Rx drug prices

New Campaign Focuses on Federal and State Solutions to Cut Drug Prices Now

WASHINGTON—AARP recently released the following statement from  Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond. The statement is in response to seven drug company executives’ testimonies given at the Senate Finance Committee hearing, “Drug Pricing in America: A Prescription for Change, Part II.”

50-Plus Voters Were Largest Voting Bloc in Montana’s Midterm Election

You are invited to join us for a Conversation with Montana Governor Steve Bullock.

Association to fight for issues critical to aging Montanans; Members urged to ask their legislators to support 2019 agenda  

AARP Montana is fighting for commonsense solutions to support Montana's unsung heroes

Signing up for the AARP Action Network is your ticket to staying informed and making a difference on issues of importance to the 50-plus.

When Montana’s Legislature convenes its biennial session on Jan. 7, lawmakers will address several critical priorities for 50-plus residents.

Congress did a good thing earlier this year when it passed a law to help America’s seniors pay less for their prescription drugs. But now, big drug companies are spending millions trying to strong-arm members of Congress into breaking the deal just to boost their own profits.